Austin W. Marxe & David M. Greenhouse’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-61,000	Closed	-$1.45M	–	148
2014 Q1	$1.45M	Sell	61,000 -563,100	-90%	-$8.16M	0.16%	105
2013 Q4	$6.67M	Sell	624,100 -171,640	-22%	-$1.9M	0.71%	46
2013 Q3	$10.6M	Sell	795,740 -54,260	-6%	-$858K	1.3%	26
2013 Q2	$11.2M	Buy	+850,000	New	+$11.5M	1.5%	19

Other funds holding ECYT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAAMCP

Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ECYT Position: Q2 2014 in Review

Austin W. Marxe & David M. Greenhouse sold out of Endocyte, Inc. Common Stock (ECYT) in Q2 2014, closing a stake of 61,000 shares — an estimated $1.45M sold.

Austin W. Marxe & David M. Greenhouse first reported a position in ECYT in Q2 2013 and held it in 4 quarters. The position peaked at $11.2M in Q2 2013. 101 funds tracked by Wall St. Rank hold ECYT as of Q2 2014.

Austin W. Marxe & David M. Greenhouse reported no remaining Endocyte, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
Austin W. Marxe & David M. Greenhouse sold 61,000 Endocyte, Inc. Common Stock shares in Q2 2014, an estimated $1.45M.
Austin W. Marxe & David M. Greenhouse first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 4 quarters.
Austin W. Marxe & David M. Greenhouse's Endocyte, Inc. Common Stock position peaked at $11.2M in Q2 2013.
101 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q2 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q2 2014, filed 8 Aug 2014.